Amgen (AMGN) has teamed up with YouTube megastar MrBeast to raise awareness and funding for pediatric cancer research through a high-profile video campaign.
The collaboration was featured in MrBeast’s video titled “I Helped 100 Kids Fight Cancer,” which reached the creator’s enormous global audience.
MrBeast’s YouTube channel boasts over 500 million subscribers, making it one of the largest and most influential platforms on the internet today.
Amgen used the partnership to spread its messaging to a demographic that traditional pharmaceutical advertising rarely reaches effectively or consistently.
The biotech giant is one of the world’s leading pharmaceutical companies, with a long-standing focus on serious illnesses including cancer and rare diseases.
Pediatric cancer remains one of the most underfunded areas of medical research relative to the scale of its impact on children and families worldwide.
By aligning with a creator of MrBeast’s reach and reputation, Amgen gains access to younger audiences who may not engage with conventional healthcare communications or media.
MrBeast, whose philanthropic video format has become a signature part of his brand, regularly produces content centred on helping individuals facing serious hardship or illness.
The partnership reflects a broader trend of pharmaceutical and biotech companies exploring non-traditional media channels to build public awareness around specific disease areas.
Amgen’s involvement in the video signals a growing recognition within the industry that digital creators can serve as credible and effective vehicles for health-focused messaging.
The campaign is positioned not only as a marketing exercise but also as a genuine fundraising and awareness effort targeting childhood cancer support.
As pharmaceutical companies face increasing scrutiny over advertising practices, partnerships rooted in charitable content offer a reputationally safer route to audience engagement.